drugset / Trial / NCT00005921

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

NCT00005921 ↗

Completed 18 enrolled Merck Sharp & Dohme LLC
Open-labelTreatment

Summary

The purpose of this study is to see if it is safe to give L-743,872 to men with candidal esophagitis, an AIDS-related yeast infection in the esophagus.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Caspofungin Other / unclassified — Intravenous